Static and dynamic pupillary features in graves disease without orbitopathy

被引:0
作者
Kuskonmaz, Serife Mehlika [1 ]
Kocer, Ali Mert [2 ]
Onder, Cagatay Emir [1 ]
Sekeroglu, Mehmet Ali [3 ]
机构
[1] Ankara Numune Training & Res Hosp, Dept Endocrinol & Metab Dis, Ankara, Turkiye
[2] Ulucanlar Eye Training & Res Hosp, Dept Ophthalmol, Ankara, Turkiye
[3] Bilkent City Hosp, Dept Ophthalmol, Ankara, Turkiye
关键词
Static pupillary measurements; Dynamic pupillary measurements; Thyroid eye disease; Graves disease; Hyperthyroidism; SYMPATHETIC OVERACTIVITY; PUPILLOMETRY;
D O I
10.1007/s10792-024-03355-8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PurposePupillary contraction and dilatation are organized by the autonomic nervous system, which can also be affected by Graves' disease (GD). In this study, it was aimed to investigate the static and dynamic pupillary responses of Graves' patients in the hyperthyroid and euthyroid periods and to compare these results with the values obtained from healthy controls. Methods48 eyes of 24 newly diagnosed Graves' patients with clinical activity score <= 2 and 46 eyes of 23 age- and sex-matched healthy controls were included in the study. Patients with GD were evaluated separately in the hyperthyroid phase and after euthyroidism was achieved. After a detailed ophthalmological examination, patients undergone automatic quantitative testing to obtain static (scotopic, mesopic, low photopic, and high photopeak pupil diameters) and dynamic (pupillary contraction amplitude, latency, velocity and duration, and pupil dilation latency, velocity and duration) pupil measurements. ResultsA statistically significant difference was found between the control [4.7 mm (3.7-6.9)] and hyperthyroid [5.1 mm (3.6-7.8)] groups for mesopic pupil diameter (p = 0.003). Dynamic pupillometry measurements showed that hyperthyroid and euthyroid groups had greater pupil dilation delay and lower pupil dilation rate compared to the control group (p < 0.05 for all). ConclusionEven in the absence of orbitopathy, patients with GD have autonomic dysregulation of pupillary functions. These changes, which prevail in the hyperthyroid phase, do not reverse when the TSH receptor antibody titer drops and the patient becomes euthyroid. Future studies are needed to elucidate the mechanism of these pupillary changes in GD.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Significance of HLA in Graves' disease and Graves' orbitopathy in Asian and Caucasian populations - a systematic review
    Stasiak, Magdalena
    Stasiak, Bartlomiej
    Zawadzka-Starczewska, Katarzyna
    Lewinski, Andrzej
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] Comparative assessment of gut microbial composition and function in patients with Graves’ disease and Graves’ orbitopathy
    T.-T. Shi
    Z. Xin
    L. Hua
    H. Wang
    R.-X. Zhao
    Y.-L. Yang
    R.-R. Xie
    H.-Y. Liu
    J.-K. Yang
    Journal of Endocrinological Investigation, 2021, 44 : 297 - 310
  • [43] Comparative assessment of gut microbial composition and function in patients with Graves' disease and Graves' orbitopathy
    Shi, T-T
    Xin, Z.
    Hua, L.
    Wang, H.
    Zhao, R-X
    Yang, Y-L
    Xie, R-R
    Liu, H. Y.
    Yang, J-K
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (02) : 297 - 310
  • [44] Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy
    Ueland, Hans Olav
    Ulvik, Arve
    Lovas, Kristian
    Wolff, Anette S. B.
    Breivik, Lars Ertesvag
    Stokland, Ann-Elin Meling
    Rodahl, Eyvind
    Nilsen, Roy Miodini
    Husebye, Eystein
    Ueland, Grethe Astrom
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (06) : 1290 - 1297
  • [45] Outcomes following surgical decompression for dysthyroid orbitopathy (Graves' disease)
    Leong, Samuel C.
    White, Paul S.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2010, 18 (01) : 37 - 43
  • [46] TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy
    Siderova, Mira
    Hristozov, Kiril
    Tsukeva, Aleksandra
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (02): : 221 - 226
  • [47] Graves' Orbitopathy Activation after Radioactive Iodine Therapy with and without Steroid Prophylaxis
    Vannucchi, G.
    Campi, I.
    Covelli, D.
    Dazzi, D.
    Curro, N.
    Simonetta, S.
    Ratiglia, R.
    Beck-Peccoz, P.
    Salvi, M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09) : 3381 - 3386
  • [48] Graves disease: Clinical features and treatment results
    Crivellaro, C
    Oberhofer, R
    Leimgruber, K
    Amor, H
    ACTA MEDICA AUSTRIACA, 2001, 28 (02) : 47 - 51
  • [49] Statins Decrease the Risk of Orbitopathy in Newly Diagnosed Patients with Graves Disease
    Nilsson, Anton
    Tsoumani, Kleoniki
    Planck, Tereza
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (05) : 1325 - 1332
  • [50] Natural course of mild Graves’ orbitopathy: is it a chronic remitting or a transient disease?
    P. Anagnostis
    K. Boboridis
    F. Adamidou
    M. Kita
    Journal of Endocrinological Investigation, 2017, 40 : 257 - 261